COVID-19: consider cytokine storm syndromes and immunosuppression

The Lancet - Tập 395 Số 10229 - Trang 1033-1034 - 2020
Puja Mehta1, Daniel F. McAuley2,3, Michael Brown4, Emilie Sanchez5, Rachel Tattersall6,7, Jessica Manson8
1Centre for Inflammation and Tissue Repair, UCL Respiratory, Division of Medicine, University College London, London, UK
2Regional Intensive Care Unit, Royal Victoria Hospital, Belfast, UK
3Wellcome-Wolfson Institute for Experimental Medicine, Queen’s University Belfast, Belfast, UK
4Hospital for Tropical Diseases, University College London Hospital, London NW1 2PG, UK
5Department of Clinical Virology, University College London Hospital, London NW1 2PG, UK
6Department of Rheumatology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK
7Sheffield Children's Hospital NHS Foundation Trust, Sheffield, UK
8Department of Rheumatology, University College London Hospital, London NW1 2PG, UK

Tóm tắt

Từ khóa


Tài liệu tham khảo

Ruan, 2020, Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China, Intensive Care Med

Ramos-Casals, 2014, Adult haemophagocytic syndrome, Lancet, 383, 1503, 10.1016/S0140-6736(13)61048-X

Karakike, 2019, Macrophage activation-like syndrome: a distinct entity leading to early death in sepsis, Front Immunol, 10, 55, 10.3389/fimmu.2019.00055

Seguin, 2016, Pulmonary involvement in patients with hemophagocytic lymphohistiocytosis, Chest, 149, 1294, 10.1016/j.chest.2015.11.004

Huang, 2020, Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China, Lancet, 395, 497, 10.1016/S0140-6736(20)30183-5

Russell, 2020, Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury, Lancet, 395, 473, 10.1016/S0140-6736(20)30317-2

Shakoory, 2016, Interleukin-1 receptor blockade is associated with reduced mortality in sepsis patients with features of macrophage activation syndrome: reanalysis of a prior phase iii trial, Crit Care Med, 44, 275, 10.1097/CCM.0000000000001402

Richardson, 2020, Baricitinib as potential treatment for 2019-nCoV acute respiratory disease, Lancet, 395, e30, 10.1016/S0140-6736(20)30304-4

Fardet, 2014, Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome, Arthritis Rheumatol, 66, 2613, 10.1002/art.38690